Scott Kelly is presenting here today: https://p
Post# of 145782
![](/assets/46931549/no_avatar_available_thumb.jpg)
https://patch.com/massachusetts/boston/calend...ummit-2022
2:00 pm Driving Innovation in Patient Selection: Rethinking Inclusion & Exclusion Criteria
Scott Kelly
Chief Medical Officer, CytoDyn
Synopsis
Investigating clinical trials for NASH in HIV-infected patients
Evaluating novel biomarker outcomes in NASH and considering comorbidities
Beyond NASH: driving studies in cardiovascular and metabolic disorders
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)